Moreover, exposure to chemotherapy drugs such as cytarabine leads to a surge in FLT3 ligand (FLT3LG) expression in AML cells and stroma, which increases IC50 values for TKIs in vitro and attenuates the efficacy of TKIs in vivo [8, 14–16]. The gene discussed is FLT3; the disease is acute myeloid leukemia.